| |
| |
|
| Insider
Information: |
Westphal Christoph H |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
6,222,903 |
|
|
Indirect Shares
|
9,212,891 |
|
|
| Direct
Value |
$11,889,861 |
|
|
|
Indirect Value
|
$384,228,726 |
|
|
| Total
Shares |
15,435,794 |
|
|
| Total
Value |
$396,118,587 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2004-06-25 |
0 |
2004-06-25 |
76,648 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director, 10% Owner |
2004-05-27 |
0 |
2004-06-03 |
2,409,970 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Executive Chairman, Di... |
2015-06-30 |
665,224 |
2015-06-30 |
1,500,063 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director, 10% Owner |
2014-03-07 |
701,927 |
2014-03-07 |
3,825,421 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
10% Owner |
2018-10-16 |
3,941,118 |
2018-10-16 |
0 |
Premium* |
|
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
2021-07-20 |
914,634 |
2021-07-20 |
1,400,789 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VSTM |
Verastem, Inc. |
President and CEOOfficer |
• • • |
2012-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
125,714 |
|
- |
|
| VSTM |
Verastem, Inc. |
President and CEOOfficer |
• • • |
2012-01-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
502,857 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
701,927 |
|
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEOOfficer |
• • – |
2015-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,902,926 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • • |
2004-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
2,510,527 |
2,409,970 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
4,905,930 |
74,227 |
|
- |
|
| VSTM |
Verastem, Inc. |
President and CEO |
• • • |
2012-02-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,269,841 |
2,269,841 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,301,127 |
3,301,127 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
President & Chief Exec Officer |
• • • |
2012-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
206,612 |
709,469 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Chief Executive Officer |
• • • |
2012-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,826 |
738,195 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2014-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
25,826 |
716,206 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Executive Chairman |
• • – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,622 |
689,411 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • – |
2015-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
2,384,764 |
2,384,764 |
0 |
- |
|
| TCRX |
Tscan Therapeutics, Inc. |
10% Owner |
– – • |
2021-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,145,505 |
1,145,505 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Chief Executive Officer |
• • • |
2013-01-29 |
4 |
AB |
$10.00 |
$3,000 |
D/D |
300 |
712,369 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-04-27 |
4 |
AB |
$22.15 |
$5,406 |
D/D |
244 |
3,904,253 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-06-22 |
4 |
AB |
$19.76 |
$5,495 |
D/D |
278 |
3,906,375 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-06-01 |
4 |
AB |
$18.15 |
$5,501 |
D/D |
303 |
3,905,502 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-06-15 |
4 |
AB |
$19.37 |
$5,502 |
D/D |
284 |
3,906,097 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-05-18 |
4 |
AB |
$17.04 |
$5,504 |
D/D |
323 |
3,905,199 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-04-13 |
4 |
AB |
$19.64 |
$5,538 |
D/D |
282 |
3,903,743 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-07-06 |
4 |
AB |
$16.20 |
$5,540 |
D/D |
342 |
3,907,003 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-07-20 |
4 |
AB |
$16.45 |
$5,543 |
D/D |
337 |
3,907,664 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-04-06 |
4 |
AB |
$21.18 |
$5,548 |
D/D |
262 |
3,903,461 |
0 |
- |
|
| SLRX |
Salarius Pharmaceuticals,... |
President and CEO |
• • • |
2015-06-08 |
4 |
AB |
$17.88 |
$5,560 |
D/D |
311 |
3,905,813 |
0 |
- |
|
137 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
